SuperworthPhibro Animal Health EPS PAHC
Diluted earnings per share by quarter and over the last twelve months, from 2012.
- Last 12 months, to Jun 30, 2026
- $2.44
- Latest quarter, Q4 FY26
- $0.53
- +26% on a year earlier
- Fiscal year 2026
- $2.44
- +107% on the year before
Phibro Animal Health's earnings per share was $2.44 over the twelve months to Jun 30, 2026, up 107% on a year earlier.
In its latest quarter, Q4 FY26, it was $0.53, up 26% on the same quarter a year before.
Over the five fiscal years to FY2026 it grew 13% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | $2.44 | +107% |
| FY2025 | $1.18 | +1867% |
| FY2024 | $0.06 | −93% |
| FY2023 | $0.81 | −33% |
| FY2022 | $1.21 | −10% |
| FY2021 | $1.34 | +63% |
| FY2020 | $0.82 | −39% |
| FY2019 | $1.35 | −16% |
| FY2018 | $1.60 | −1% |
| FY2017 | $1.62 | −21% |
| FY2016 | $2.06 | +36% |
| FY2015 | $1.52 | +15100% |
| FY2014 | $0.01 | −99% |
| FY2013 | $0.83 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q4 FY26 | $0.53 | +26% | $2.44 | |
| Q3 FY26 | $0.59 | +16% | $2.33 | |
| Q2 FY26 | $0.67 | +738% | $2.25 | |
| Q1 FY26 | $0.65 | +282% | $1.66 | |
| Q4 FY25 | $0.42 | +2000% | $1.18 | |
| Q3 FY25 | $0.51 | +143% | $0.78 | |
| Q2 FY25 | $0.08 | +167% | $0.48 | |
| Q1 FY25 | $0.17 | n/a | $0.43 | |
| Q4 FY24 | $0.02 | −93% | $0.06 | |
| Q3 FY24 | $0.21 | −16% | $0.32 | |
| Q2 FY24 | $0.03 | −83% | $0.36 | |
| Q1 FY24 | −$0.20 | −300% | $0.51 |
Against its peers
Companies in Drug Manufacturers - General nearest Phibro Animal Health's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| PAHCPhibro Animal Health | $2.44 | +107% a year |
| ANIPANI Pharmaceuticals | $4.70 | |
| ANABAnaptysbio | $4.57 | |
| PCRXPacira BioSciences | $0.35 | |
| OMEROmeros | $1.52 | |
| HRMYHarmony Biosciences | $3.09 | −0% a year |
| PBHPrestige Consumer Healthcare | $3.57 | −16% a year |
| AMPHAmphastar Pharmaceuticals | $1.70 | −36% a year |
| NRIXNurix Therapeutics | $2.31 | |
| ABUSArbutus Biopharma | $0.78 | |
| COLLCollegium Pharmaceutical | $1.24 | +19% a year |
| Peer median | $2.00 |
Where Phibro Animal Health ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Phibro Animal Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.